195 related articles for article (PubMed ID: 36628391)
1. Use of Botulinum Toxin in Spasmodic Dysphonia: A Review of Recent Studies.
Khan HA
Cureus; 2023 Jan; 15(1):e33486. PubMed ID: 36628391
[TBL] [Abstract][Full Text] [Related]
2. Neurectomy and Myomectomy for Treatment of Spasmodic Dysphonia.
Ryan W; Alnouri G; Sataloff RT
J Voice; 2024 Jan; 38(1):239-242. PubMed ID: 35738960
[TBL] [Abstract][Full Text] [Related]
3. [Spasmodic Dysphonia].
Tokashiki R
Brain Nerve; 2023 Jan; 75(1):15-22. PubMed ID: 36574969
[TBL] [Abstract][Full Text] [Related]
4. Sulcus vocalis in spasmodic dysphonia-A retrospective study.
Nerurkar NK; Agrawal D; Joshi D
Am J Otolaryngol; 2021; 42(3):102940. PubMed ID: 33545449
[TBL] [Abstract][Full Text] [Related]
5. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study.
Cha W; Jang JY; Wang SG; Kang JH; Jo MG
J Voice; 2017 May; 31(3):378.e19-378.e24. PubMed ID: 27520509
[TBL] [Abstract][Full Text] [Related]
6. Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin.
Meyer TK; Hu A; Hillel AD
Laryngoscope; 2013 Nov; 123 Suppl 6():S1-14. PubMed ID: 23818277
[TBL] [Abstract][Full Text] [Related]
7. The effect of unilateral thalamic deep brain stimulation on the vocal dysfunction in a patient with spasmodic dysphonia: interrogating cerebellar and pallidal neural circuits.
Poologaindran A; Ivanishvili Z; Morrison MD; Rammage LA; Sandhu MK; Polyhronopoulos NE; Honey CR
J Neurosurg; 2018 Feb; 128(2):575-582. PubMed ID: 28304188
[TBL] [Abstract][Full Text] [Related]
8. Bilateral Vocal Fold Medialization: A Treatment for Abductor Spasmodic Dysphonia.
Dewan K; Berke GS
J Voice; 2019 Jan; 33(1):45-48. PubMed ID: 29132808
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
Blitzer A; Brin MF; Stewart CF
Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
11. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
[TBL] [Abstract][Full Text] [Related]
12. Improved vocal quality and decreased vocal effort after botulinum toxin treatment for laryngeal dystonia.
Leung JS; Rosenbaum A; Holmberg J; Villarroel P; Napolitano C; BadÃa PI; Lagos-Villaseca A
Auris Nasus Larynx; 2024 Feb; 51(1):106-112. PubMed ID: 37365040
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
[TBL] [Abstract][Full Text] [Related]
14. Life Threatening Delayed Complication of Botulinum Toxin Injection for Treatment of Spasmodic Dysphonia.
Yershov D; Partridge R
Prague Med Rep; 2020; 121(2):114-117. PubMed ID: 32553095
[TBL] [Abstract][Full Text] [Related]
15. Bilateral Posterior Cricoarytenoid Myoneurectomy for Abductor Spasmodic Dysphonia.
Benito DA; Ferster APO; Sataloff RT
J Voice; 2020 Jan; 34(1):127-129. PubMed ID: 30174222
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin for the treatment of spasmodic dysphonia.
Gibbs SR; Blitzer A
Otolaryngol Clin North Am; 2000 Aug; 33(4):879-94. PubMed ID: 10918666
[TBL] [Abstract][Full Text] [Related]
17. Spasmodic dysphonia: clinical features and effects of botulinum toxin therapy in 169 patients-an Australian experience.
Tisch SH; Brake HM; Law M; Cole IE; Darveniza P
J Clin Neurosci; 2003 Jul; 10(4):434-8. PubMed ID: 12852881
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
Sulica L; Blitzer A; Brin MF; Stewart CF
Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of spasmodic dysphonia with botulinum toxin].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
[TBL] [Abstract][Full Text] [Related]
20. Spasmodic dysphonia: An overview of clinical features and treatment options.
Sanuki T
Auris Nasus Larynx; 2023 Feb; 50(1):17-22. PubMed ID: 35697560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
